» Articles » PMID: 2474524

Enhancing Effect of Ethanol on Aflatoxin B1-induced Hepatocarcinogenesis in Male ACI/N Rats

Overview
Specialty Oncology
Date 1989 Jun 1
PMID 2474524
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The modifying effect of ethanol (EtOH) on aflatoxin B1 (AFB1)-induced hepatocarcinogenesis was examined in male ACI/N rats by chronic treatment at the post-initiation phase. Rats received an ip injection of AFB1 (1.5 mg/kg) twice a week for 10 weeks (a total of 20 doses). Following a week of acclimation, they were given 10% EtOH as drinking water for 56 weeks. The effect of EtOH on the hepatocarcinogenesis was evaluated in terms of the incidence of altered hepatocellular foci and neoplasms at the end of the experiment. Exposure to AFB1 alone induced a substantial number of altered foci (6.98 iron-excluding foci/cm2) in rats. The number of altered liver cell foci in rats receiving AFB1 followed by EtOH was significantly increased (26.39 iron-excluding foci/cm2). In the rats given EtOH after AFB1, the total area and mean diameter of both iron-excluding foci and altered foci identified in hematoxylin and eosin-stained sections were significantly higher than in the rats exposed to AFB1 alone. The incidence of liver cell tumors of the group given AFB1 and EtOH (3/15, 20%) was higher than that of the group treated with AFB1 alone (0/14, 0%). Treatment with EtOH alone for 56 weeks did not induce either. These results indicate an enhancing effect of EtOH on AFB1-induced hepatocarcinogenesis when it is given in the promotion phase.

Citing Articles

Dose-dependence of promotion of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis by ethanol: evidence for a threshold.

Kushida M, Wanibuchi H, Morimura K, Kinoshita A, Kang J, Puatanachokchai R Cancer Sci. 2005; 96(11):747-57.

PMID: 16271068 PMC: 11158716. DOI: 10.1111/j.1349-7006.2005.00110.x.


Hepatocyte growth factor enhancement of preneoplastic hepatic foci development in rats treated with diethylnitrosamine and N-ethyl-N-hydroxyethylnitrosamine.

Yaono M, Hasegawa R, Mizoguchi Y, Futakuchi M, Nakamura T, Ito N Jpn J Cancer Res. 1995; 86(8):718-23.

PMID: 7559093 PMC: 5920913. DOI: 10.1111/j.1349-7006.1995.tb02459.x.

References
1.
Takada A, Nei J, Takase S, Matsuda Y . Effects of ethanol on experimental hepatocarcinogenesis. Hepatology. 1986; 6(1):65-72. DOI: 10.1002/hep.1840060113. View

2.
Toskulkao C, Taycharpipranai S, Glinsukon T . Enhanced hepatotoxicity of aflatoxin B1 by pretreatment of rats with ethanol. Res Commun Chem Pathol Pharmacol. 1982; 36(3):477-91. View

3.
Williams G, Hirota N, Rice J . The resistance of spontaneous mouse hepatocellular neoplasms to iron accumulation during rapid iron loading by parenteral administration and their transplantability. Am J Pathol. 1979; 94(1):65-74. PMC: 2042232. View

4.
Teschke R, Minzlaff M, OLDIGES H, Frenzel H . Effect of chronic alcohol consumption on tumor incidence due to dimethylnitrosamine administration. J Cancer Res Clin Oncol. 1983; 106(1):58-64. DOI: 10.1007/BF00399898. View

5.
Bloomer J, Waldmann T, MCINTIRE K, KLATSKIN G . alpha-fetoprotein in noneoplastic hepatic disorders. JAMA. 1975; 233(1):38-41. DOI: 10.1001/jama.233.1.38. View